Salmeterol

May 19, 2020

Cipla Files ANDA for Generic Version of GSK's Advair Diskus®

Mar 18, 2020

Pharmascience Inc. launches pms-FLUTICASONE PROPIONATE/SALMETEROL DPI for the maintenance treatment of asthma and COPD

Oct 01, 2019

Sosei Heptares Notes the Announcement of Positive Results from Phase III IRIDIUM Study of Inhaled Combination QVM149 in Patients with Uncontrolled Asthma

Oct 01, 2019

Lannett Enters Into Distribution Agreement For Generic ADVAIR DISKUS®

May 18, 2019

Mylan Presents Equivalence and Device Usability Data on Wixela(TM) Inhub(TM) Compared to Advair Diskus® at American Thoracic Society International Conference

Feb 12, 2019

Mylan Launches Wixela(TM) Inhub(TM) (fluticasone propionate and salmeterol inhalation powder, USP), the First Generic of ADVAIR DISKUS® (fluticasone propionate and salmeterol inhalation powder), at a List Price 70% Less than the Brand

Jan 31, 2019

Mylan Announces FDA Approval of Wixela(TM) Inhub(TM) (fluticasone propionate and salmeterol inhalation powder, USP), First Generic of ADVAIR DISKUS® (fluticasone propionate and salmeterol inhalation powder)

Jan 30, 2019

FDA approves first generic Advair Diskus

Sep 14, 2017

Global Asthma & COPD Therapies Market 2017-2027